|
Press Releases |
|
|
|
Friday, October 25, 2024 |
|
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' |
The 17th C.C. Tan Life Science Award ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the C.C. Tan Life Science Industrialization Award . more info >> |
|
Friday, August 30, 2024 |
|
Hua Medicine Announces 2024 Interim Results |
Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
華領醫藥公佈2024年中期業績 |
全球首創新藥雙功能葡萄糖激酶激活劑(GKA)多格列艾汀(商品名:華堂寧®)于2023年底成功納入《國家基本醫療保險、工傷保險和生育保險藥品目錄》(“國家醫保藥品目錄”)。華領醫藥與商業化合作夥伴拜耳以及80家一級經銷商共同推動多格列艾汀的商業化,開始進入中國31個省級醫藥市場。 more info >> |
|
华领医药公布2024年中期业绩 |
华领医药(“公司”,香港联交所股份代号:2552)宣布公司及其附属公司截至2024年6月30日止,6个月(“报告期”)未经审核的综合业绩,以及公司上半年业务进展和未来业务展望。 more info >> |
|
Friday, August 25, 2023 |
|
华领医药公布2023年中期业绩 |
-- 全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(商品名:华堂宁®)于2022年9月在中国获批上市。 more info >> |
|
華領醫藥公佈2023年中期業績 |
-- 全球首創新藥葡萄糖激酶激活劑(GKA)多格列艾汀(商品名:華堂寧®)於2022年9月在中國獲批上市。 more info >> |
|
Hua Medicine Announces 2023 Interim Results |
First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. more info >> |
|
Monday, October 10, 2022 |
|
华领医药全球首创新药葡萄糖激酶激活剂华堂宁(R)获批上市 有望拓展中国2型糖尿病治疗新格局 |
华领医药(「公司」,香港联交所股份代号:2552.HK)今天宣布,公司研发的全球首创(first-in-class)新药葡萄糖激酶激活剂(GKA)华堂宁®(多格列艾汀片,dorzagliatin,HMS5552)已于10月8日获得中国国家药品监督管理局(NMPA)的上市批准。 more info >> |
|
華領醫藥全球首創新藥葡萄糖激酶激活劑華堂寧(R)獲批上市 有望拓展中國2型糖尿病治療新格局 |
華領醫藥(「公司」,香港聯交所股份代號:2552.HK)今天宣佈,公司研發的全球首創(first-in-class)新藥葡萄糖激酶激活劑(GKA)華堂寧®(多格列艾汀片,dorzagliatin,HMS5552)已於10月8日獲得中國國家藥品監督管理局(NMPA)的上市批准。 more info >> |
|
Hua Medicine's Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China |
Hua Medicine (the "Company", HKEx Stock Code: 2552.HK) today announces that the New Drug Application (NDA) of HuaTangNing (dorzagliatin tablets, HMS5552), a first-in-class glucokinase activator (GKA) developed by the Company has been approved by the National Medical Products Administration (NMPA) of China on October 8th for two indications more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 12:00: JST
|
|
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App
Nov 22, 2024 10:00 HKT/SGT
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 22, 2024 09:00 HKT/SGT
|
|
|
アレス・マネジメント、東京オフィス開設でアジア事業を拡充
Nov 22, 2024 09:00: JST
|
|
|
Yahoo Finance Invest Asia 2024 - Disrupting Finance: Innovations Shaping The Future
Nov 22, 2024 08:50 HKT/SGT
|
|
|
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
|
|
|
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry
Nov 21, 2024 21:29 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 21, 2024 21:20 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 21:00: JST
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 20:19 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|